Chemours price target lowered to $19 from $20 at BMO Capital

BMO Capital lowered the firm’s price target on Chemours (CC) to $19 from $20 and keeps an Outperform rating on the shares. Despite the company managing through the HVAC headwinds and TSS – Thermal & Specialized Solutions – looking better than originally expected, the Q1 guide for breakeven profitability in Titanium Technologies/Advanced Performance Materials segments makes the guide a challenge and sent the stock lower, the analyst tells investors in a research note.